Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada)

Background: Schizophrenia is a chronic debilitating disease that affects ~110,000 Canadians (0.55% lifetime prevalence). Risperidone long-acting injection (RLAI) is the first injectable, long-acting, atypical antipsychotic drug marketed in Canada. Objective: The aim of this study was to assess the c...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Ganesan, Soma, McKenna, Mario, Procyshyn, Ric M., Zipursky, Sheldon
Formáid: Artigo
Teanga:Inglês
Foilsithe: Elsevier 2007
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3969908/
https://ncbi.nlm.nih.gov/pubmed/24692772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2007.12.002
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla